| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/15/2004 | EP1456171A1 Substituted cyclohexane derivatives |
| 09/15/2004 | EP1456170A1 Aminoacetonitrile derivatives and their use for controlling parasites |
| 09/15/2004 | EP1456165A1 Induction of apoptosis in cancer cells |
| 09/15/2004 | EP1456163A2 Improvements in pharmaceutical compositions |
| 09/15/2004 | EP1456160A2 Vitamin d analogues |
| 09/15/2004 | EP1455900A1 Methods of treating bacterial infections in dogs and cats |
| 09/15/2004 | EP1455899A1 Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne |
| 09/15/2004 | EP1455873A1 Metered dose inhaler |
| 09/15/2004 | EP1455858A2 Catheter composition and uses thereof |
| 09/15/2004 | EP1455837A1 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics |
| 09/15/2004 | EP1455835A2 Method of modulating release of saccharides and uses thereof |
| 09/15/2004 | EP1455830A1 Selective anesthetic agents and methods of identifying the same |
| 09/15/2004 | EP1455829A1 Treating vascular disease by inhibiting myeloid differentiation factor 88 |
| 09/15/2004 | EP1455827A1 Pecam-1 modulation |
| 09/15/2004 | EP1455823A2 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 09/15/2004 | EP1455817A2 Staphylococcus aureus exopolysaccharide and process |
| 09/15/2004 | EP1455813A2 Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung disease |
| 09/15/2004 | EP1455810A1 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 09/15/2004 | EP1455807A2 METHOD FOR USE OF IGF-BINDING PROTEIN FOR SELECTIVE SENSITIZATION OF TARGET CELLS i IN VIVO /i |
| 09/15/2004 | EP1455804A2 Use of nanoparticles as carriers for biocides in ophthalmic compositions |
| 09/15/2004 | EP1455803A1 Pharmaceutical composition for use in ophthalmology and rhinology |
| 09/15/2004 | EP1455802A1 Chitosan oligosaccharides and uses thereof |
| 09/15/2004 | EP1455801A1 Ribavirin granulate for producing coated tablets |
| 09/15/2004 | EP1455799A1 Pharmaceutical combinations of adenosine a-2a and beta-2-adrenergic receptor agonists |
| 09/15/2004 | EP1455798A2 Phosphorothioate-modified oligonucleotide as anti-restenosis agent |
| 09/15/2004 | EP1455797A2 Pseudopterosin compounds of symbiodinium spp isolated from pseudopterogorgia elisabethae |
| 09/15/2004 | EP1455796A1 Method for the treatment of bone disorders |
| 09/15/2004 | EP1455795A1 Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists |
| 09/15/2004 | EP1455794A2 PHARMACEUTICAL COMPOSITION COMPRISING A ClC-2 CHANNEL OPENER |
| 09/15/2004 | EP1455793A2 Antidiabetic formulation and method |
| 09/15/2004 | EP1455792A1 Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 09/15/2004 | EP1455791A1 Method for administering birb 796 bs |
| 09/15/2004 | EP1455790A1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition |
| 09/15/2004 | EP1455789A2 Imiquimod therapies |
| 09/15/2004 | EP1455786A1 Use of a compound in the treatment of sleep disorders and the like in providing refreshedness on waking and a method for the treatment of grogginess therewith |
| 09/15/2004 | EP1455785A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/15/2004 | EP1455784A1 Analgesic delivery systems and methods of use |
| 09/15/2004 | EP1455783A1 Combination of a selective pde4 inhibitor and an adrenergic beta-2 receptor agonist |
| 09/15/2004 | EP1455782A1 High-concentration stable meloxicam solutions for needle-less injection |
| 09/15/2004 | EP1455781A1 Use of anastrozole for the treatment of post-menopausal women having early breast cancer |
| 09/15/2004 | EP1455780A1 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 09/15/2004 | EP1455779A1 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 09/15/2004 | EP1455778A2 Methods for the treatment of peripheral neural and vascular ailments |
| 09/15/2004 | EP1455777A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 09/15/2004 | EP1455776A1 A non-arrhythmogenic metabolite of oxybutynin |
| 09/15/2004 | EP1455775A2 Methods and compositions for modulating the immune system and uses thereof |
| 09/15/2004 | EP1455774A1 Pharmaceutical composition for treating obesity |
| 09/15/2004 | EP1455773A1 2-aryl-propionic acids and pharmaceutical compositions containing them |
| 09/15/2004 | EP1455772A1 Medium for radical treatment of tumors, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation |
| 09/15/2004 | EP1455771A2 2-indanylamino derivatives for the therapy of chronic pain |
| 09/15/2004 | EP1455770A1 Use of norepinephrine reuptake inhibitors for the treatment of tic disorders |
| 09/15/2004 | EP1455769A2 Processes for preparing crystalline and amorphous mupirocin calcium |
| 09/15/2004 | EP1455768A1 Respiratory infection prevention and treatment with terpene-containing compositions |
| 09/15/2004 | EP1455767A2 Method and compositions for treating respiratory pathologies |
| 09/15/2004 | EP1455765A2 Use of protease-activated receptor-2 inhibitor in the manufacture of a medicament for treating delayed hypersensitivity |
| 09/15/2004 | EP1455761A1 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 09/15/2004 | EP1455760A1 Ultrapure oral fludara formulation with a fast releasing active substance |
| 09/15/2004 | EP1455758A1 Directly compressible formulations of azithromycin |
| 09/15/2004 | EP1455757A2 Methods for wet granulating azithromycin |
| 09/15/2004 | EP1455756A1 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 09/15/2004 | EP1455754A2 Pharmaceutical compositions in particulate form |
| 09/15/2004 | EP1455751A1 Zero-order sustained released dosage forms and method of making the same |
| 09/15/2004 | EP1455750A1 Viscoelastic ophthalmic compositions comprising hyaluronic acid and chondroitin sulphate |
| 09/15/2004 | EP1455744A2 Cosmetic and/or dermatological active ingredient combination |
| 09/15/2004 | EP1455734A1 Compositions comprising phenyl-glycine derivatives |
| 09/15/2004 | EP1455730A1 Isotretinoin nanoparticulate compositions |
| 09/15/2004 | EP1455700A2 Methods and compositions related to irm compounds and toll-like receptor pathways |
| 09/15/2004 | EP1455697A1 Vaginal delivery of drugs |
| 09/15/2004 | EP1455682A2 Biologically active complex |
| 09/15/2004 | EP1455605A1 Soft drink replacer |
| 09/15/2004 | EP1455603A1 Stimulation of in vivo production of proteins with formulation comprising leucine |
| 09/15/2004 | EP1455602A1 Modified methionine rich food products and process for their manufacture |
| 09/15/2004 | EP1455601A1 Composition for promotion of bone growth and maintenance of bone health |
| 09/15/2004 | EP1455588A1 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis |
| 09/15/2004 | EP1455582A1 Adhesion inhibition of fungi |
| 09/15/2004 | EP1455581A2 Inhibition of the asexual reproduction of fungi |
| 09/15/2004 | EP1455580A2 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832 |
| 09/15/2004 | EP1427323A4 Use of s-nitrosothiol signaling to treat disordered control of breathing |
| 09/15/2004 | EP1401421A4 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor |
| 09/15/2004 | EP1395587A4 Process for the preparation of imipenem |
| 09/15/2004 | EP1370547B1 Benzoaxathiepin derivatives and their use as medicines |
| 09/15/2004 | EP1368338A4 Method of preparing lansoprazole and its intermediate |
| 09/15/2004 | EP1363902B1 Chemical compounds |
| 09/15/2004 | EP1326862B1 Crystalline monohydrate of tiotropiumbromide, method for producing the same and the use thereof in the production of a medicament |
| 09/15/2004 | EP1322325A4 Inhibiting hepatitis c virus processing and replication |
| 09/15/2004 | EP1311275B1 A synthetic bulk laxative |
| 09/15/2004 | EP1305317B1 Dihydroporphyrin derivatives and their uses |
| 09/15/2004 | EP1299395B1 Oxazinoquinolones useful for the treatment of viral infections |
| 09/15/2004 | EP1294729B1 2-aminoalkyl-thieno[2,3-d]pyrimidines |
| 09/15/2004 | EP1274686A4 Process for preparing 2-(4-chlorobenzolamino) -3- 2(1h) -quinolinon-4-yl]proprionic acid |
| 09/15/2004 | EP1254135B1 Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 09/15/2004 | EP1246638B1 Use of exendins and agonists thereof for the treatment of hypertriglyceridemia |
| 09/15/2004 | EP1244442B1 Method for detecting nucleotide synthesis inhibitors having fewer side effects |
| 09/15/2004 | EP1233747B1 Use of flavones and/or isoflavones from plant extracts |
| 09/15/2004 | EP1224161B1 Nitroxy derivatives of (r) and (s)-carnitine |
| 09/15/2004 | EP1221851B1 Antiviral compositions for tissue paper |
| 09/15/2004 | EP1220668B1 Use of diminazene-di-aceturate and/or pentamidine for treating malaria |
| 09/15/2004 | EP1212317B1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/15/2004 | EP1202992B1 Ascididemin derivatives and their therapeutic applications |
| 09/15/2004 | EP1196408B1 Respiratory syncytial virus replication inhibitors |